BrightSpring Health 服务 BTSG

Mr. Jon B. Rousseau has served as our President and Chief Executive Officer since 2016, and the Chairman of our Board of Directors since 2024. Prior to joining the Company, Mr. Rousseau was an executive vice president at Kindred Healthcare, Inc. with multiple leadership roles from June 2013 - July 2016, including president of Kindred Rehabilitation Services, and prior to that, president of the Care Management Division and Kindred at Home, Kindred's home health, hospice, home care and home-based primary care businesses. Before Kindred, Mr. Rousseau held a number of senior leadership positions at other market-leading healthcare product and technology companies, including vice president of global marketing, strategy, and commercial development at Mylan, Inc. and global senior director of the continuous glucose monitoring franchise with Medtronic PLC (2006 - 2013). For the first part of his career, Mr. Rousseau worked at Friedman Fleischer & Lowe LLC in private equity (1998 - 2005) and at Morgan Stanley in investment banking (1996 - 1998). He received his MBA from Harvard Business School and his A.B. degree from Princeton University.

Ms. Jennifer Phipps has served as our Executive Vice President and Chief Financial Officer since March 2025. Previously, Ms. Phipps served as the Company's Senior Vice President and Chief Accounting Officer since January 2017 and as Principal Accounting Officer since the Company's initial public offering in January 2024, as well as Chief Financial Officer of the Company's Home Health and Hospice business lines since January 2023. In her capacity at the Company, Ms. Phipps has also managed and overseen the organization's procurement, real estate, and tax departments and played a leadership role in all financial systems processes and enhancements and all financially related acquisitions and divestitures activities. Prior to joining the Company in 2017, Ms. Phipps served in various accounting and SEC reporting leadership roles over time at Cardinal Health from 2009 to 2017. Prior to that, she worked in public accounting at Ernst & Young from 2003 to 2009. Ms. Phipps holds an active CPA license and earned her Bachelor of Science in Business Administration in accounting and Master of Accounting from The Ohio State University.

Ms. Lisa Nalley has served as our Chief of Staff since February 2017 and Senior Vice President of Human Resources since August 2020, and also serves as the leader of the Executive Project Management Office. Prior to joining the Company, Ms. Nalley was a business consultant at Barrel Consulting, LLC, and before that, Ms. Nalley served as Sr. Director of Strategic Initiatives for Kindred Rehabilitation Services and Kindred at Home, as well as several other business improvement roles from 2003 to 2016 at Kindred Healthcare, Inc. Ms. Nalley has an A.A.S. in Applied Science in paralegal science from Marshall University.

Mr. Scott A. Greenwell has served as our Executive Vice President and President of PharMerica's Home and Community pharmacy since June 2025. Dr. Greenwell previously served as President of Pharmacy Solutions at Humana Inc., where he managed a $48 billion pharmacy solutions business, including Pharmacy Benefits Management, Home Delivery, and Specialty Pharmacy. Dr. Greenwell holds a Doctorate of Pharmacy from the University of Kentucky and has completed executive education programs at Harvard Business School and the University of Chicago Booth School of Business.

JMs. Jennifer Yowler has served as our President of PharMerica since March 2022. Previously, Ms. Yowler served as PharMerica's Chief Financial Officer since June 2019. Ms. Yowler brings more than 20 years of experience in finance and operations at multiple Fortune 500 companies in the long-term care and healthcare industry. Prior to joining PharMerica, Ms. Yowler served as Chief Financial Officer at Partners Pharmacy from October 2015 to June 2019 and held several senior level positions at Omnicare from October 2004 to September 2015. Ms. Yowler began her career at PricewaterhouseCoopers in the audit and assurance group, working on various clients in the healthcare and insurance spectrum. Ms. Yowler obtained a Bachelor of Science degree in Business Administration and Accounting from Ohio University. On June 16, 2025, Ms. Yowler transitioned from President of PharMerica to Senior Vice President, Sales and Account Management for PharMerica.

Ms. Olivia F. Kirtley has served as a member of our Board of Directors since 2024. Ms. Kirtley is the president and co-founder of KirtleyWood LLC. Ms. Kirtley is a former Treasurer, Vice President and Chief Financial Officer at Vermont American Corporation and a former senior manager at the predecessor to the accounting firm Ernst & Young LLP. Ms. Kirtley also served as President and Chairman of the International Federation of Accountants, Chairman of the American Institute of Certified Public Accountants (AICPA), and Chairman of the AICPA Board of Examiners. Ms. Kirtley previously served as a director of U.S. Bancorp from 2006 to 2023, Papa Johns International, Inc. from 2003 to 2023, ResCare, Inc. from 1998 to 2019 and Rangold Resources Ltd. from 2017 to 2019. She holds a B.S. in Accounting from Florida Southern College, and a Master's Degree in Taxation from Georgia State University. She is a Certified Public Accountant and Chartered Global Management Accountant.

Dr. Steven B. Miller has served as a member of our Board of Directors since 2024. Dr. Miller served as the Chief Clinical Officer for Cigna from 2018 to 2022, transitioning to an expert advisor role in 2022 for Cigna's efforts across clinical policy, quality, and performance programs. Previously, Dr. Miller was the Chief Medical Officer at Express Scripts from 2005 to 2018 and the Chief Medical Officer at Barnes-Jewish Hospital from 1999 to 2005. He is currently the Chief Medical Officer at MediBeacon, a medical technology company specializing in fluorescent tracer agents and transdermal measurement. Dr. Miller received his medical degree from the University of Missouri-Kansas City. He trained in the Pathology and Research fellowship at the University of Alabama at Birmingham. He was the William J. and Dorothy Fish Kerr Fellow in Cardiology at the University of California, San Francisco. Dr. Miller also did Internal Medicine training at the University of Colorado and Nephrology and Transplantation at Washington University in St. Louis. He earned his MBA at the Olin School of Business at Washington University in St. Louis.

On June 11, 2026, the board of directors of BrightSpring Health Services, Inc. appointed Dr. Nigam H. Shah to the Board as a Class III director. Dr. Shah joined Stanford University as an Assistant Professor of Medicine in 2011, was tenured in 2015, and promoted to Professor of Medicine and Biomedical Data Science in 2020. Dr. Shah currently serves as the Chief Data Scientist at Stanford Healthcare and Associate Dean for Health Information and Data Science. His work focuses on leveraging technology and data insights to improve patient outcomes while bringing artificial intelligence (AI) to clinical use, safely, ethically and cost-effectively. He has co-founded three companies and serves on the Boards of Prealize Health and Atropos Health. Dr. Shah is also a co-founder of the Coalition for Health AI (CHAI).

Mr. Johnny Kim has served as a member of our Board of Directors since 2019. Mr. Kim is a Managing Director and has served as a member of the Health Care industry team within KKR & Co.'s Americas Private Equity platform since 2015. Mr. Kim currently serves on the Board of Directors of Argenta, Brightline, Clarify Health Solutions, Global Medical Response, SkinSpirit, SunFire, and Therapy Brands. Prior to joining KKR & Co., Mr. Kim was with Goldman Sachs (2013-2015) where he was involved in a number of mergers, acquisitions, and financing transactions. He holds an Honors B.A. with distinction from the Ivey Business School, Western University and was an Ivey Scholar.

Mr. Hunter Craig has served as a member of our Board of Directors since 2020. Mr. Craig joined KKR & Co. in 2020 and is a member of the Health Care industry team within KKR & Co.'s Americas Private Equity platform. He currently serves on the Board of Directors of 123Dentist, Cotiviti, DentalXChange, Heartland Dental, and Henry Schein. Prior to joining KKR & Co., Mr. Craig was a vice president at GTCR (2013-2020), where he was involved in investments across the healthcare sector. He began his career as an investment banking analyst in the global industrial & services group at Credit Suisse. Mr. Craig holds a B.B.A., magna cum laude, in Accountancy and Theology from the University of Notre Dame and an M.B.A. from Harvard Business School.